High Tower Advisors, LLC Merrimack Pharmaceuticals Inc Transaction History

High Tower Advisors, LLC

  • $68.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$3.19 - $5.73 $48,009 - $86,236
-15,050 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$2.95 - $4.15 $295 - $415
-100 Reduced 0.66%
15,050 $58,000
Q2 2018

Aug 14, 2018
SELL
$3.86 - $7.61 $57,900 - $114,150
-15,000 Reduced 49.75%
15,150 $74,000
Q3 2017

Nov 14, 2017
BUY
$9.13 - $11.72 $275,269 - $353,358
30,150
30,150 $438,000

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email